Treatment of symptoms of seasonal or perennial rhinitis, especially in moderate to severe persistent allergy in adults, adolescents and children between the age of 2 and 11 years.
Treatment of nasal polyps in adult patients ≥18 years.
Treatment of symptoms associated with mild to moderate uncomplicated acute rhinosinusitis in adults and children ≥12 years where signs or symptoms of bacterial infection are not present.